76209-02-4

Basic information

• Product Name: Benzenethiol, 4-bromo-2-nitro-
• CAS NO: 76209-02-4
• Molecular Formula: C6H4BrNO2S
• Molecular Weight: 234.073
• Mol File: 76209-02-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzenethiol, 4-bromo-2-nitro-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenethiol, 4-bromo-2-nitro-(76209-02-4)
• EPA Substance Registry System: Benzenethiol, 4-bromo-2-nitro-(76209-02-4)

Safety Data

• Hazardous Substances Data: 76209-02-4(Hazardous Substances Data)

Upstream product

• 3460-18-2 1,4-dibromo-2-nitrobenzene 
• 3226-41-3 4-bromobenzenediazonium tetrafluoroborate 
• 17333-82-3 4-bromo-benzenediazonium ion 
• 157645-54-0 4-bromo-2-nitro-1-thiocyanato-benzene 
• 16588-24-2 4-bromo-1-chloro-2-nitrobenzene 

Downstream Products

• 199475-45-1 5-bromo-1,3-benzothiazol-2(3H)-one 
• 1293364-12-1 5-(3-acetylphenyl)-1,3-benzothiazol-2(3H)-one 
• 1293364-13-2 5-(3-methoxyphenyl)-1,3-benzothiazol-2(3H)-one 
• 1293364-14-3 3-methyl-5-phenyl-1,3-benzothiazol-2(3H)-one 
• 1293364-15-4 5-(3-acetylphenyl)-3-methyl-1,3-benzothiazol-2(3H)-one 
• 1293364-16-5 3-(3-methyl-2-oxo-2,3-dihydro-1,3-benzothiazol-5-yl)benzonitrile 
• 1293364-17-6 5-(3-aminophenyl)-3-methyl-1,3-benzothiazol-2(3H)-one 
• 1293364-18-7 5-(3-hydroxyphenyl)-3-methyl-1,3-benzothiazol-2(3H)-one 
• 768-11-6 5-bromo-benzthiazole 
• 93933-49-4 2-amino-4-bromobenzenethiol 
• 7038-31-5 2-amino-4-bromo-benzenethiol dimer 
• 76209-05-7 4,4′-dibromo-2,2′-dinitrodiphenyl disulfide 

Relevant articles and documents

COMPOUNDS FOR TREATMENT OF DRUG RESISTANT AND PERSISTENT TUBERCULOSIS

Described herein are compounds and compositions for treating drug resistant and persistent tuberculosis. Also described herein is a method of screening for identifiying biofilm formation inhibitors.

Fused bicyclic-substituted amines as histamine-3 receptor ligands

Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands and methods for using such compounds and compositions.

Fused bicyclic-substituted amines as histamine-3 receptor ligands

Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands and methods for using such compounds and compositions.